Is it acceptable for pharmaceutical companies to oppose cheaper generic alternatives of their medication in countries where the majority of people who require that medication cannot afford to pay for...

Is it acceptable for pharmaceutical companies to oppose cheaper generic alternatives of their medication in countries where the majority of people who require that medication cannot afford to pay for it? In general, is it acceptable that the same drugs cost vastly different amounts in different countries—even within the developed world?